Table 3.
Mortality and risk analysis in patients with pleural infection cases
| Characteristic | Pleural Infection | |||
| Total patients (N=100) | 30-day mortality N (%) |
90-day mortality N (%) |
365-day mortality N (%) |
|
| (A) Mortality among 100 pneumococcal pleural infection cases with different clinical features and RAPID severity scores | ||||
| Disease characteristics | ||||
| Pus | 59 | 0 (0) | 0 (0) | 1 (2) |
| No pus | 41 | 9 (22) | 12 (29) | 12 (29) |
| Loculation present | 49 | 8 (16) | 10 (20) | 12 (25) |
| No loculation detected | 51 | 1 (2) | 2 (4) | 5 (10) |
| Fibrinolytics used | 33 | 4 (12) | 6 (18) | 11 (33) |
| Surgical management* | 29 | 0 (0) | 0 (0) | 0 (0) |
| Loculation present | 23 | 0 (0) | 0 (0) | 0 (0) |
| No loculation | 6 | 0 (0) | 0 (0) | 0 (0) |
| No surgical management | 71 | 9 (13) | 12 (17) | 17 (24) |
| RAPID risk group | ||||
| Low | 36 | 1 (3) | 1 (3) | 3 (8) |
| Medium | 46 | 2 (4) | 3 (7) | 4 (9) |
| High | 18 | 6 (33) | 10 (55) | 13 (72) |
| (B) Cox regression analysis for risk factors in patients with pleural infection | ||||||
| Analysis | Factor | Beta (β) estimate | HR | 95% CI | Р value | |
| 30-day mortality | RAPID group |
Low | – | – | – | – |
| Medium | 13.52 | 12.04 | 0.23 to 39.87 | 0.674 | ||
| High | 28.51 | 19.33 | 0.55 to 92.33 | 0.638 | ||
| Age | −0.002 | 0.998 | 0.96 to 1.05 | 0.921 | ||
| Loculation | 1.705 | 5.502 | 0.99 to 103 | 0.111 | ||
| 90-day mortality | RAPID group |
Low | – | – | – | – |
| Medium | 0.573 | 1.773 | 0.19 to 38.77 | 0.642 | ||
| High | 2.709 | 15.01 | 1.24 to 40.06 | 0.049 | ||
| Age | 0.015 | 1.02 | 0.97 to 1.07 | 0.55 | ||
| Loculation | 1.582 | 4.86 | 1.27 to 31.87 | 0.043 | ||
| 365-day mortality | RAPID group age |
Low | – | – | – | – |
| Medium | 0.573 | 1.773 | 0.19 to 38.77 | 0.642 | ||
| High | 2.709 | 15.01 | 1.24 to 40.06 | 0.049 | ||
| Age | 0.027 | 1.028 | 0.99 to 1.07 | 0.188 | ||
| Loculation | 1.041 | 2.836 | 1.04 to 9.00 | 0.05 | ||
RAPID (Renal, Age, Purulence, Infection source, and Dietary factors) score 0–2 represents low risk, 3–4 medium risk and 5–7 high risk.
Proportional hazard assumptions were tested by visual assessment of the Kaplan-Meier survival curve, log(-log) plots and Schoenfeld Residuals (online supplemental data 8).
*Eighteen patients underwent surgery after fibrinolytic usage.